Study of LY2409021 in Participants With Type 1 Diabetes

NCT01640834 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: LY2409021
DRUG: Placebo
DRUG: Glucagon

Sponsor

Eli Lilly and Company